Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiome in modulating immune checkpoint inhibitors
Xiang Li, Shaoqiang Zhang, Gang Guo, et al.
EBioMedicine (2022) Vol. 82, pp. 104163-104163
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 80
Promising dawn in tumor microenvironment therapy: engineering oral bacteria
Zifei Wang, Wansu Sun, Ruixue Hua, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 65
Polysaccharides from Spirulina platensis: Extraction methods, structural features and bioactivities diversity
Xiaopeng Ai, Peiling Yu, Xiangyu Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 231, pp. 123211-123211
Closed Access | Times Cited: 47
Fecal microbiota transplantation: current challenges and future landscapes
Abbas Yadegar, Haggai Bar‐Yoseph, Tanya Monaghan, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Open Access | Times Cited: 45
Strategies for the development of metalloimmunotherapies
Xiaoqi Sun, Xingwu Zhou, Xiaoyue Shi, et al.
Nature Biomedical Engineering (2024) Vol. 8, Iss. 9, pp. 1073-1091
Closed Access | Times Cited: 33
Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases
Mohamed Kamel, Sami Aleya, Majed Alsubih, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 2, pp. 217-217
Open Access | Times Cited: 23
Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications
Tong Xiao, Juyeun Lee, Timothy D. Gauntner, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 338-355
Closed Access | Times Cited: 22
Unraveling host regulation of gut microbiota through the epigenome–microbiome axis
Michael Le Pepke, Søren B. Hansen, Morten T. Limborg
Trends in Microbiology (2024) Vol. 32, Iss. 12, pp. 1229-1240
Open Access | Times Cited: 18
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies
Marc C. Pulanco, Anne Tranberg Madsen, Ankit Tanwar, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 694-713
Closed Access | Times Cited: 38
Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant
Rossella Salemi, Silvia Vivarelli, Daria Ricci, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 30
Human microbiomes in cancer development and therapy
Chenglai Xia, Jiyan Su, Can Liu, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 27
Potential Pathophysiological Pathways in the Complex Relationships between OSA and Cancer
Manuel Sánchez‐de‐la‐Torre, Carolina Cubillos‐Zapata, Olivia J. Veatch, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1061-1061
Open Access | Times Cited: 26
The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors
Camille Moeckel, Katrina Bakhl, Ilias Georgakopoulos-Soares, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6710-6710
Open Access | Times Cited: 25
Type 1 diabetes: A new vision of the disease based on endotypes
Craig Sinclair Weston, Bernhard O. Boehm, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 2
Open Access | Times Cited: 8
Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Cancer Management and Research (2025) Vol. Volume 17, pp. 171-192
Open Access | Times Cited: 1
Regulatory role of gut microbiota in immunotherapy of hepatocellular carcinoma
Jiajia Du, Yan Guan, Erlei Zhang
Hepatology International (2025)
Closed Access | Times Cited: 1
The potential role of the microbiota in prostate cancer pathogenesis and treatment
Nicolò Pernigoni, Christina Guo, Lewis Gallagher, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 12, pp. 706-718
Closed Access | Times Cited: 22
Immune‐related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity
Namrata Singh, Anne M. Hocking, Jane H. Buckner
Immunological Reviews (2023) Vol. 318, Iss. 1, pp. 81-88
Closed Access | Times Cited: 20
Fusobacterium nucleatum: a novel immune modulator in breast cancer?
Alexa Little, Mark Tangney, Michael M. Tunney, et al.
Expert Reviews in Molecular Medicine (2023) Vol. 25
Open Access | Times Cited: 18
Exploring the underlying correlation between microbiota, immune system, hormones, and inflammation with breast cancer and the role of probiotics, prebiotics and postbiotics
Muhammad Summer, Ayesha Sajjad, Shaukat Ali, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 4
Closed Access | Times Cited: 7
Placebo-resistant gut bacteria: Akkermansia muciniphila spp. and Familial Mediterranean fever disease
Elya S. Pepoyan, Francesco Marotta, Anahit Manvelyan, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 6
Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes
Jiexi Yan, Lu Yang, Qingmiao Ren, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
A narrative review on the use of probiotics in several diseases. Evidence and perspectives
Daniela Campaniello, Antonio Bevilacqua, Barbara Speranza, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 13
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top